新型冠状病毒肺炎：风湿病学家面临的新挑战。 - Suppr

COVID-19: the new challenge for rheumatologists.

作者信息

Ferro Francesco, Elefante Elena, Baldini Chiara, Bartoloni Elena, Puxeddu Ilaria, Talarico Rosaria, Mosca Marta, Bombardieri Stefano

机构信息

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Rheumatology Unit, Department of Medicine, University of Perugia, Italy.

出版信息

Clin Exp Rheumatol. 2020 Mar-Apr;38(2):175-180. doi: 10.55563/clinexprheumatol/r3k9l6. Epub 2020 Mar 24.

DOI:10.55563/clinexprheumatol/r3k9l6

PMID:32207680

Abstract

摘要

相似文献

COVID-19: the new challenge for rheumatologists.

Clin Exp Rheumatol. 2020 Mar-Apr;38(2):175-180. doi: 10.55563/clinexprheumatol/r3k9l6. Epub 2020 Mar 24.

SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets - What to Learn from Rheumatologists.

J Rheumatol. 2020 Oct 1;47(10):1588-1589. doi: 10.3899/jrheum.200657. Epub 2020 May 25.

Reply to Rheumatologists' perspective on coronavirus disease 19: is heparin the dark horse for COVID-19?

Clin Rheumatol. 2020 Jul;39(7):2099-2100. doi: 10.1007/s10067-020-05145-w. Epub 2020 May 9.

Drs. Cron and Chatham reply.

J Rheumatol. 2020 Oct 1;47(10):1590-1591. doi: 10.3899/jrheum.200679. Epub 2020 May 25.

Rheumatologists and Pulmonologists at Temple University Weather the COVID-19 Storm Together.

J Rheumatol. 2020 Nov 1;47(11):1723. doi: 10.3899/jrheum.200740. Epub 2020 Jun 8.

How and why are rheumatologists relevant to COVID-19?

Joint Bone Spine. 2020 Jul;87(4):279-280. doi: 10.1016/j.jbspin.2020.04.006. Epub 2020 Apr 30.

Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.

RMD Open. 2020 Oct;6(3). doi: 10.1136/rmdopen-2020-001323.

Hydroxychloroquine: A Potential Ethical Dilemma for Rheumatologists during the COVID-19 Pandemic.

J Rheumatol. 2020 Jun 1;47(6):783-786. doi: 10.3899/jrheum.200369. Epub 2020 Apr 2.

Hope.

Ann Rheum Dis. 2020 Jul;79(7):986. doi: 10.1136/annrheumdis-2020-217666. Epub 2020 Apr 27.

COVID-19-Associated Encephalopathy and Cytokine-Mediated Neuroinflammation.

Ann Neurol. 2020 Oct;88(4):860-861. doi: 10.1002/ana.25855. Epub 2020 Aug 14.

引用本文的文献

[Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion].

Rev Colomb Reumatol. 2021 Apr-Jun;28(2):134-140. doi: 10.1016/j.rcreu.2020.05.021. Epub 2020 Jun 26.

Baricitinib and Pulse Steroids Combination Treatment in Hyperinflammatory COVID-19: A Rheumatological Approach in the Intensive Care Unit.

Int J Mol Sci. 2024 Jul 2;25(13):7273. doi: 10.3390/ijms25137273.

One Virus, Two Diseases: Evaluation of Clinical and Immunological Differences in Covid-19 and Multisystem Inflammatory Syndrome Cases.

Sisli Etfal Hastan Tip Bul. 2024 Apr 5;58(1):82-90. doi: 10.14744/SEMB.2023.23316. eCollection 2024.

Effect of traditional therapeutics on prevalence and clinical outcomes of coronavirus disease 2019 in Chinese patients with autoimmune diseases.

J Transl Autoimmun. 2023 Dec 12;8:100227. doi: 10.1016/j.jtauto.2023.100227. eCollection 2024 Jun.

Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?

Int J Mol Sci. 2022 Nov 12;23(22):13951. doi: 10.3390/ijms232213951.

Common bone marrow signature in COVID-19-associated multisystem inflammatory syndrome in children: A first-wave small case series experience.

Pediatr Blood Cancer. 2022 Nov;69(11):e29919. doi: 10.1002/pbc.29919. Epub 2022 Aug 20.

Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients.

Mediterr J Rheumatol. 2022 Mar 31;33(1):68-74. doi: 10.31138/mjr.33.1.68. eCollection 2022 Mar.

Safety and efficacy of colchicine in COVID-19 patients: A systematic review and meta-analysis of randomized control trials.

PLoS One. 2022 Apr 5;17(4):e0266245. doi: 10.1371/journal.pone.0266245. eCollection 2022.

COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.

Expert Rev Mol Med. 2022 Mar 15;24:e13. doi: 10.1017/erm.2022.10.

Colchicine Against SARS-CoV-2 Infection: What is the Evidence?

Rheumatol Ther. 2022 Apr;9(2):379-389. doi: 10.1007/s40744-022-00425-0. Epub 2022 Feb 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

COVID-19: the new challenge for rheumatologists.

作者信息

Ferro Francesco, Elefante Elena, Baldini Chiara, Bartoloni Elena, Puxeddu Ilaria, Talarico Rosaria, Mosca Marta, Bombardieri Stefano

机构信息

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Rheumatology Unit, Department of Medicine, University of Perugia, Italy.

出版信息

Clin Exp Rheumatol. 2020 Mar-Apr;38(2):175-180. doi: 10.55563/clinexprheumatol/r3k9l6. Epub 2020 Mar 24.

DOI:10.55563/clinexprheumatol/r3k9l6

PMID:32207680

Abstract

摘要

相似文献

COVID-19: the new challenge for rheumatologists.

Clin Exp Rheumatol. 2020 Mar-Apr;38(2):175-180. doi: 10.55563/clinexprheumatol/r3k9l6. Epub 2020 Mar 24.

SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets - What to Learn from Rheumatologists.

J Rheumatol. 2020 Oct 1;47(10):1588-1589. doi: 10.3899/jrheum.200657. Epub 2020 May 25.

Reply to Rheumatologists' perspective on coronavirus disease 19: is heparin the dark horse for COVID-19?

Clin Rheumatol. 2020 Jul;39(7):2099-2100. doi: 10.1007/s10067-020-05145-w. Epub 2020 May 9.

Drs. Cron and Chatham reply.

J Rheumatol. 2020 Oct 1;47(10):1590-1591. doi: 10.3899/jrheum.200679. Epub 2020 May 25.

Rheumatologists and Pulmonologists at Temple University Weather the COVID-19 Storm Together.

J Rheumatol. 2020 Nov 1;47(11):1723. doi: 10.3899/jrheum.200740. Epub 2020 Jun 8.

How and why are rheumatologists relevant to COVID-19?

Joint Bone Spine. 2020 Jul;87(4):279-280. doi: 10.1016/j.jbspin.2020.04.006. Epub 2020 Apr 30.

Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.

RMD Open. 2020 Oct;6(3). doi: 10.1136/rmdopen-2020-001323.

Hydroxychloroquine: A Potential Ethical Dilemma for Rheumatologists during the COVID-19 Pandemic.

J Rheumatol. 2020 Jun 1;47(6):783-786. doi: 10.3899/jrheum.200369. Epub 2020 Apr 2.

Hope.

Ann Rheum Dis. 2020 Jul;79(7):986. doi: 10.1136/annrheumdis-2020-217666. Epub 2020 Apr 27.

COVID-19-Associated Encephalopathy and Cytokine-Mediated Neuroinflammation.

Ann Neurol. 2020 Oct;88(4):860-861. doi: 10.1002/ana.25855. Epub 2020 Aug 14.

引用本文的文献

[Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion].

Rev Colomb Reumatol. 2021 Apr-Jun;28(2):134-140. doi: 10.1016/j.rcreu.2020.05.021. Epub 2020 Jun 26.

Baricitinib and Pulse Steroids Combination Treatment in Hyperinflammatory COVID-19: A Rheumatological Approach in the Intensive Care Unit.

Int J Mol Sci. 2024 Jul 2;25(13):7273. doi: 10.3390/ijms25137273.

One Virus, Two Diseases: Evaluation of Clinical and Immunological Differences in Covid-19 and Multisystem Inflammatory Syndrome Cases.

Sisli Etfal Hastan Tip Bul. 2024 Apr 5;58(1):82-90. doi: 10.14744/SEMB.2023.23316. eCollection 2024.

Effect of traditional therapeutics on prevalence and clinical outcomes of coronavirus disease 2019 in Chinese patients with autoimmune diseases.

J Transl Autoimmun. 2023 Dec 12;8:100227. doi: 10.1016/j.jtauto.2023.100227. eCollection 2024 Jun.

Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?

Int J Mol Sci. 2022 Nov 12;23(22):13951. doi: 10.3390/ijms232213951.

Common bone marrow signature in COVID-19-associated multisystem inflammatory syndrome in children: A first-wave small case series experience.

Pediatr Blood Cancer. 2022 Nov;69(11):e29919. doi: 10.1002/pbc.29919. Epub 2022 Aug 20.

Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients.

Mediterr J Rheumatol. 2022 Mar 31;33(1):68-74. doi: 10.31138/mjr.33.1.68. eCollection 2022 Mar.

Safety and efficacy of colchicine in COVID-19 patients: A systematic review and meta-analysis of randomized control trials.

PLoS One. 2022 Apr 5;17(4):e0266245. doi: 10.1371/journal.pone.0266245. eCollection 2022.

COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.

Expert Rev Mol Med. 2022 Mar 15;24:e13. doi: 10.1017/erm.2022.10.

Colchicine Against SARS-CoV-2 Infection: What is the Evidence?

Rheumatol Ther. 2022 Apr;9(2):379-389. doi: 10.1007/s40744-022-00425-0. Epub 2022 Feb 2.

COVID-19: the new challenge for rheumatologists.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

COVID-19: the new challenge for rheumatologists.

作者信息

机构信息

出版信息

相似文献

引用本文的文献